Apyx Medical

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$19,164
$12,877
$11,373
$9,430
Gross Profit
-2,012
8,297
7,083
5,665
EBITDA
232
-332
-2,164
-2,609
EBIT
11
-464
-2,296
-2,747
Net Income
-1,299
-1,984
-3,778
-4,150
Net Change In Cash
19,164
12,877
11,373
9,430
Free Cash Flow
-2,805
-4,054
-1,498
-757
Cash
31,740
25,135
29,301
31,011
Basic Shares
42,163
40,729
40,729
35,542

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$52,844
$48,102
$52,349
$44,510
Gross Profit
19,033
29,360
33,759
29,131
EBITDA
-5,791
-16,801
-18,112
-22,006
EBIT
-6,446
-17,400
-18,804
-22,896
Net Income
-11,211
-23,463
-18,713
-23,184
Net Change In Cash
52,844
48,102
52,349
44,510
Cost of Revenue
-21,073
Free Cash Flow
-9,115
-18,769
-5,782
-21,290
Cash
31,740
31,741
43,652
10,192
Basic Shares
42,163
35,542
34,622
34,516

Earnings Calls

QuarterEPS
2025-12-31
-$0.03
2025-09-30
-$0.05
2025-06-30
$0.09
2025-03-31
-$0.10